Related Experiment Video
Updated: Mar 3, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2
Orith Waisbourd-Zinman1, Lea F Surrey2, Anna E Schwartz1
1Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Insights
Two siblings with a mild form of Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) showed a favorable outcome. This case highlights novel ABCB11 gene variants associated with a less severe PFIC2 presentation.
Area of Science:
- Hepatology
- Genetics
- Rare Diseases
Background:
- Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) is a severe genetic liver disease.
- Mutations in the ABCB11 gene impair bile salt export, leading to liver damage.
- Current treatments have variable success, often necessitating liver transplantation.
Observation:
- Two siblings presented with mild PFIC2 symptoms in infancy, including cholestasis and vitamin deficiencies.
- Both siblings recovered and remained asymptomatic after infancy.
- Genetic analysis revealed compound heterozygosity for two novel ABCB11 missense mutations: p.C68Y and p.R832H.
Findings:
- The identified ABCB11 variants (p.C68Y and p.R832H) are associated with an unusually mild PFIC2 phenotype.
- These patients did not require standard PFIC2 medical interventions.
- This is the first report detailing these specific variants in a mild PFIC2 presentation.
Implications:
- These findings expand the understanding of genotype-phenotype correlations in PFIC2.
- Novel ABCB11 variants may represent a milder spectrum of the disease.
- Further research into these variants could inform personalized treatment strategies for PFIC2.
Abstract:
Progressive Familial Intrahepatic Cholestasis type 2 (PFIC2) is a rare cholestatic disorder diagnosed in infancy or childhood that can lead to severe hepatic fibrosis and liver failure. Mutations in the ABCB11 gene result in a deficiency of the bile salt export protein (BSEP) and accumulation of bile inside the hepatocytes. Hepatocellular carcinoma is another condition associated with severe forms of deletion mutations in the ABCB11 gene. Treatment options including ursodeoxycholic acid biliary diversion have mixed outcomes and some patients require liver transplantation. Here, we describe two siblings with an extremely mild form of PFIC2 inherited from heterozygous parents. The elder sibling had acute liver failure at the age of six months and both siblings had pruritus, cholestasis, coagulopathy and fat-soluble-vitamin deficiencies in infancy but have been asymptomatic past infancy. Genetic testing of the siblings revealed that each were compound heterozygotes for two missense mutations of the ABCB11 gene: p.C68Y and p.R832H. Medical treatment typical for PFIC2 has not been necessary for either patient. This is the first report of these variants following a mild course in two affected patients.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Inborn Errors of Metabolism
Pedigree Analysis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase